{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T06:56:38Z","timestamp":1773730598585,"version":"3.50.1"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jns.2023.120830","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T08:24:21Z","timestamp":1696839861000},"page":"120830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Autoimmune and paraneoplastic neurological disorders: A review of relevant neuroimaging findings"],"prefix":"10.1016","volume":"454","author":[{"given":"Sema","family":"Akkus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Elkhooly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suban","family":"Amatya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kriti","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanika","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuf","family":"Kagzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erum","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda L.","family":"Piquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shruti","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sijin","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Tapia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohan","family":"Samant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sri Raghav","family":"Sista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shitiz","family":"Sriwastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jns.2023.120830_bb0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","article-title":"Paraneoplastic syndromes of the CNS","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.jns.2023.120830_bb0010","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1055\/s-0041-1733788","article-title":"Neurologic complications in patients with cancer","volume":"41","author":"Holroyd","year":"2021","journal-title":"Semin. Neurol."},{"issue":"9","key":"10.1016\/j.jns.2023.120830_bb0015","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41571-019-0194-4","article-title":"Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors","volume":"16","author":"Graus","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.jns.2023.120830_bb0020","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00415-019-09544-1","article-title":"Epidemiology of paraneoplastic neurological syndromes: a population-based study","volume":"267","author":"Vogrig","year":"2020","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2023.120830_bb0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/NRL.0b013e3181870aa2","article-title":"Paraneoplastic neurological syndromes: a review","volume":"15","author":"Toothaker","year":"2009","journal-title":"Neurologist."},{"key":"10.1016\/j.jns.2023.120830_bb0030","doi-asserted-by":"crossref","DOI":"10.1177\/1756286420985323","article-title":"Paraneoplastic neurological syndromes: clinical presentations and management","volume":"14","author":"Devine","year":"2021","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"5","key":"10.1016\/j.jns.2023.120830_bb0035","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1042\/cs1020475","article-title":"The immunopathogenesis of paraneoplastic neurological syndromes","volume":"102","author":"Sutton","year":"2002","journal-title":"Clin. Sci. (Lond.)"},{"issue":"1","key":"10.1016\/j.jns.2023.120830_bb0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00432-014-1745-9","article-title":"Paraneoplastic neurological syndromes associated with ovarian tumors","volume":"141","author":"Zaborowski","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jns.2023.120830_bb0045","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1750-1172-2-22","article-title":"Paraneoplastic neurological syndromes","volume":"2","author":"Honnorat","year":"2007","journal-title":"Orphanet. J. Rare Dis."},{"issue":"3","key":"10.1016\/j.jns.2023.120830_bb0050","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/cei.12185","article-title":"Paraneoplastic neurological syndromes","volume":"175","author":"Leypoldt","year":"2014","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.jns.2023.120830_bb0055","doi-asserted-by":"crossref","first-page":"e1014","DOI":"10.1212\/NXI.0000000000001014","article-title":"Updated diagnostic criteria for paraneoplastic neurologic syndromes","volume":"8","author":"Graus","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"4","key":"10.1016\/j.jns.2023.120830_bb0060","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.jns.2023.120830_bb0065","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","article-title":"Paraneoplastic syndromes of the CNS","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.jns.2023.120830_bb0070","first-page":"347","article-title":"Management of suspected viral encephalitis in adults--association of British neurologists and British infection association national guidelines","volume":"64","author":"Solomon","year":"2012","journal-title":"J. Inf. Secur."},{"issue":"1","key":"10.1016\/j.jns.2023.120830_bb0075","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00415-019-09544-1","article-title":"Epidemiology of paraneoplastic neurological syndromes: a population-based study","volume":"267","author":"Vogrig","year":"2020","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2023.120830_bb0080","doi-asserted-by":"crossref","first-page":"e1124","DOI":"10.1212\/NXI.0000000000001124","article-title":"Population-based epidemiology study of paraneoplastic neurologic syndromes","volume":"9","author":"Shah","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.jns.2023.120830_bb0085","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/archneur.56.2.172","article-title":"Antiamphiphysin antibodies are associated with various paraneoplastic neurological syndromes and tumors","volume":"56","author":"Antoine","year":"1999","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2023.120830_bb0090","doi-asserted-by":"crossref","first-page":"e1014","DOI":"10.1212\/NXI.0000000000001014","article-title":"Updated diagnostic criteria for paraneoplastic neurologic syndromes","volume":"8","author":"Graus","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"3","key":"10.1016\/j.jns.2023.120830_bb0095","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1155\/2002\/964531","article-title":"Small cell lung cancer with positive anti-Hu antibodies presenting as gastroparesis","volume":"16","author":"Moskovitz","year":"2002","journal-title":"Can. J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.jns.2023.120830_bb0100","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11912-018-0721-y","article-title":"Updates in the diagnosis and treatment of paraneoplastic neurologic syndromes","volume":"20","author":"Grativvol","year":"2018","journal-title":"Curr. Oncol. Rep."},{"issue":"1","key":"10.1016\/j.jns.2023.120830_bb0105","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s12957-021-02436-7","article-title":"Breast cancer-associated opsoclonus-myoclonus syndrome: a case report","volume":"19","author":"Kostoglou","year":"2021","journal-title":"World J. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.jns.2023.120830_bb0110","doi-asserted-by":"crossref","first-page":"e352","DOI":"10.1212\/NXI.0000000000000352","article-title":"Abnormal brain metabolism on FDG-PET\/CT is a common early finding in autoimmune encephalitis","volume":"4","author":"Probasco","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"4","key":"10.1016\/j.jns.2023.120830_bb0115","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000352","article-title":"Abnormal brain metabolismon FDG-PET\/CT is a common early finding in autoimmune encephalitis","volume":"4","author":"Probasco","year":"2017","journal-title":"Neurol. - Neuroimmunol. Neuroinflam."},{"issue":"3","key":"10.1016\/j.jns.2023.120830_bb0120","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ncl.2018.04.015","article-title":"Paraneoplastic neurologic syndromes","volume":"36","author":"Rosenfeld","year":"2018","journal-title":"Neurol. Clin."},{"issue":"5","key":"10.1016\/j.jns.2023.120830_bb0125","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/ana.26050","article-title":"Leucine zipper 4 autoantibody: a novel germ cell tumor and paraneoplastic biomarker","volume":"89","author":"Dubey","year":"2021","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.jns.2023.120830_bb0130","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1136\/jnnp-2021-326775","article-title":"Paraneoplastic cochleovestibulopathy: clinical presentations, oncological and serological associations","volume":"92","author":"Hammami","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"7","key":"10.1016\/j.jns.2023.120830_bb0135","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1468-1331.2006.01266.x","article-title":"Voltz R; paraneoplastic neurological syndrome Euronetwork. Management of paraneoplastic neurological syndromes: report of an EFNS task force","volume":"13","author":"Vedeler","year":"2006","journal-title":"Eur. J. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2023.120830_bb0140","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jamaneurol.2022.4251","article-title":"Autoimmune encephalitis misdiagnosis in adults","volume":"80","author":"Flanagan","year":"2023","journal-title":"JAMA Neurol."},{"issue":"12","key":"10.1016\/j.jns.2023.120830_bb0145","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1093\/clinchem\/hvaa254","article-title":"Neural antibody testing in patients with suspected autoimmune encephalitis","volume":"66","author":"Budhram","year":"2020","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.jns.2023.120830_bb0150","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1152\/physrev.00010.2016","article-title":"Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system","volume":"97","author":"Dalmau","year":"2017","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.jns.2023.120830_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3988\/jcn.2016.12.1.1","article-title":"The diagnosis and treatment of autoimmune encephalitis","volume":"12","author":"Lancaster","year":"2016","journal-title":"J. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2023.120830_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3988\/jcn.2016.12.1.1","article-title":"The diagnosis and treatment of autoimmune encephalitis","volume":"12","author":"Lancaster","year":"2016","journal-title":"J. Clin. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2023.120830_bb0165","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/ana.26050","article-title":"Leucine zipper 4 autoantibody: a novel germ cell tumor and paraneoplastic biomarker","volume":"89","author":"Dubey","year":"2021","journal-title":"Ann. Neurol."},{"issue":"11","key":"10.1016\/j.jns.2023.120830_bb0170","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1001\/jamaneurol.2020.2231","article-title":"Expanded clinical phenotype, oncological associations, and immunopathologic insights of paraneoplastic Kelch-like Protein-11 encephalitis","volume":"77","author":"Dubey","year":"2020","journal-title":"JAMA Neurol."},{"issue":"8","key":"10.1016\/j.jns.2023.120830_bb0175","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/epi.16282","article-title":"Seizure specificities in patients with antibody-mediated autoimmune encephalitis","volume":"60","author":"Vogrig","year":"2019","journal-title":"Epilepsia."},{"issue":"9","key":"10.1016\/j.jns.2023.120830_bb0180","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/acn3.396","article-title":"Antibodies to TRIM46 are associated with paraneoplastic neurological syndromes","volume":"4","author":"van Coevorden-Hameete","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2023.120830_bb0185","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/jnnp-2021-326656","article-title":"Characterisation of TRIM46 autoantibody-associated paraneoplastic neurological syndrome","volume":"93","author":"Valencia-Sanchez","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"2","key":"10.1016\/j.jns.2023.120830_bb0190","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12311-018-0987-5","article-title":"TRIM9 and TRIM67 are new targets in paraneoplastic cerebellar degeneration","volume":"18","author":"Do","year":"2019","journal-title":"Cerebellum"},{"issue":"4","key":"10.1016\/j.jns.2023.120830_bb0195","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ajhg.2016.03.015","article-title":"Biallelic mutations in PDE10A Lead to Loss of Striatal PDE10A and a hyperkinetic movement disorder with onset in infancy","volume":"98","author":"Diggle","year":"2016","journal-title":"Am. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.jns.2023.120830_bb0200","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/1759-7714.13009","article-title":"Paraneoplastic autoimmunity and small-cell lung cancer: neurological and serological accompaniments","volume":"10","author":"Zekeridou","year":"2019","journal-title":"Thorac Cancer"},{"issue":"24","key":"10.1016\/j.jns.2023.120830_bb0205","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1212\/WNL.0b013e31821f468f","article-title":"Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues","volume":"76","author":"Flanagan","year":"2011","journal-title":"Neurology."},{"issue":"4","key":"10.1016\/j.jns.2023.120830_bb0210","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2169\/internalmedicine.1398-18","article-title":"Transient diffusion-weighted imaging hyperintensity of the cerebellar cortex in paraneoplastic cerebellar degeneration","volume":"58","author":"Hashimoto","year":"2019","journal-title":"Intern. Med."},{"issue":"2","key":"10.1016\/j.jns.2023.120830_bb0215","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1097\/RLU.0000000000003868","article-title":"18F-FDG PET\/CT findings in a rare case of paraneoplastic vestibulocerebellar syndrome associated with isolated antiamphiphysin antibodies","volume":"47","author":"Komandla","year":"2022","journal-title":"Clin. Nucl. Med."},{"issue":"3","key":"10.1016\/j.jns.2023.120830_bb0220","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/jnnp.61.3.270","article-title":"Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes","volume":"61","author":"Honnorat","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.jns.2023.120830_bb0225","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1941874418802130","article-title":"Cerebellar Ataxia with extreme photophobia associated with Anti-SOX1 antibodies","volume":"9","author":"Alessandro","year":"2019","journal-title":"Neurohospitalist"},{"issue":"Pt 6","key":"10.1016\/j.jns.2023.120830_bb0230","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/brain\/124.6.1138","article-title":"Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients","volume":"124","author":"Graus","year":"2001","journal-title":"Brain."},{"issue":"2","key":"10.1016\/j.jns.2023.120830_bb0235","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0022-510X(99)00029-5","article-title":"Cytotoxic T lymphocyte-mediated cell death in paraneoplastic sensory neuronopathy with anti-Hu antibody","volume":"163","author":"Tanaka","year":"1999","journal-title":"J. Neurol. Sci."},{"issue":"Pt 6","key":"10.1016\/j.jns.2023.120830_bb0240","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/brain\/120.6.923","article-title":"Limbic encephalitis and small cell lung cancer. Clinical and immunological features","volume":"120","author":"Alamowitch","year":"1997","journal-title":"Brain."},{"issue":"2","key":"10.1016\/j.jns.2023.120830_bb0245","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1017\/cjn.2022.13","article-title":"Anti-Hu (ANNA-1) associated paraneoplastic sensory Neuronopathy in a large cell neuroendocrine carcinoma of the lung","volume":"50","author":"Gupta","year":"2023","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.jns.2023.120830_bb0250","first-page":"724940","article-title":"Rare association of anti-hu antibody positive paraneoplastic neurological syndrome and transitional cell bladder carcinoma","volume":"2012","author":"Lukacs","year":"2012","journal-title":"Case Rep. Urol."},{"issue":"24","key":"10.1016\/j.jns.2023.120830_bb0255","doi-asserted-by":"crossref","first-page":"e10717","DOI":"10.1097\/MD.0000000000010717","article-title":"Paraneoplastic cerebellar degeneration associated with cerebellar hypermetabolism: case report","volume":"97","author":"Abdulaziz","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"10.1016\/j.jns.2023.120830_bb0260","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/MPH.0000000000001304","article-title":"An uncommon presentation of a primary bone tumor: anti-AMPA (anti-\u03b1-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic acid) receptor limbic\/paraneoplastic encephalitis as a presenting feature of Ewing sarcoma","volume":"40","author":"Koh","year":"2018","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.jns.2023.120830_bb0265","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-225745","article-title":"Anti-AMPA receptor encephalitis associated with Medullary thyroid cancer","volume":"2018","author":"Samad","year":"2018","journal-title":"BMJ Case Rep."},{"issue":"11","key":"10.1016\/j.jns.2023.120830_bb0270","first-page":"e3581","article-title":"Thymoma-associated myasthenia gravis in a young adult with development of paraneoplastic limbic encephalitis and systemic lupus erythematosus post-thymectomy: a case report","volume":"10","author":"Liu","year":"2018","journal-title":"Cureus"},{"issue":"24","key":"10.1016\/j.jns.2023.120830_bb0275","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1212\/WNL.0000000000001682","article-title":"Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients","volume":"84","author":"H\u00f6ftberger","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2023.120830_bb0280","doi-asserted-by":"crossref","first-page":"652820","DOI":"10.3389\/fimmu.2021.652820","article-title":"Anti-Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic acid receptor encephalitis: a review","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jns.2023.120830_bb0285","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yebeh.2016.04.046","article-title":"Paraneoplastic epilepsy","volume":"61","author":"Serafini","year":"2016","journal-title":"Epilepsy Behav."},{"issue":"1","key":"10.1016\/j.jns.2023.120830_bb0290","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12883-020-01913-y","article-title":"Posterior reversible encephalopathy syndrome case report in an untreated, normotensive, ovarian cancer patient in the presence of paraneoplastic antibodies","volume":"20","author":"Barber","year":"2020","journal-title":"BMC Neurol."},{"issue":"1","key":"10.1016\/j.jns.2023.120830_bb0295","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/ijgc-2021-003077","article-title":"Paraneoplastic cerebellar degeneration associated with anti-Yo antibodies in uterine papillary serous carcinoma","volume":"32","author":"Deleuze","year":"2022","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"11","key":"10.1016\/j.jns.2023.120830_bb0300","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","article-title":"An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models","volume":"18","author":"Dalmau","year":"2019","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.jns.2023.120830_bb0305","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11307-008-0134-7","article-title":"Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates","volume":"10","author":"Basu","year":"2008","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/j.jns.2023.120830_bb0310","article-title":"Anti-CV2\/CRMP5 paraneoplastic chorea effectively managed with intravenous amantadine","volume":"9","author":"Ha","year":"2019","journal-title":"Tremor. Other Hyperkinet Mov. (N Y)."},{"issue":"11","key":"10.1016\/j.jns.2023.120830_bb0315","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1007\/s00415-021-10496-8","article-title":"Cerebellar ataxia and myeloradiculopathy associated with AP3B2 antibody: a case report and literature review","volume":"268","author":"Mange","year":"2021","journal-title":"J. Neurol."},{"issue":"10","key":"10.1016\/j.jns.2023.120830_bb0320","doi-asserted-by":"crossref","first-page":"e954","DOI":"10.1212\/WNL.0000000000008061","article-title":"Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG","volume":"93","author":"Honorat","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.jns.2023.120830_bb0325","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/practneurol-2021-003073","article-title":"Paraneoplastic neurological syndromes: a practical approach to diagnosis and management","volume":"22","author":"Binks","year":"2022","journal-title":"Pract. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2023.120830_bb0330","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol."},{"issue":"7","key":"10.1016\/j.jns.2023.120830_bb0335","doi-asserted-by":"crossref","first-page":"e32956","DOI":"10.1097\/MD.0000000000032956","article-title":"Clinical characteristics and prognosis of anti-GABABR encephalitis: a single-center experience","volume":"102","author":"Li","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jns.2023.120830_bb0340","doi-asserted-by":"crossref","first-page":"102826","DOI":"10.1016\/j.nicl.2021.102826","article-title":"Quantitative brain imaging analysis of neurological syndromes associated with anti-GAD antibodies","volume":"32","author":"Dade","year":"2021","journal-title":"Neuroimage Clin."},{"issue":"5","key":"10.1016\/j.jns.2023.120830_bb0345","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000502695","article-title":"Clinical heterogeneity in patients with glutamate decarboxylase antibody","volume":"26","author":"Huang","year":"2019","journal-title":"Neuroimmunomodulation."},{"key":"10.1016\/j.jns.2023.120830_bb0350","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ebcr.2018.04.001","article-title":"Autoimmune encephalitis associated with two antibodies","volume":"10","author":"Reyes","year":"2018","journal-title":"Epilepsy Behav Case Rep."},{"issue":"4","key":"10.1016\/j.jns.2023.120830_bb0355","doi-asserted-by":"crossref","first-page":"e1019","DOI":"10.1212\/NXI.0000000000001019","article-title":"Autoimmune global amnesia as manifestation of AMPAR encephalitis and neuropathologic findings","volume":"8","author":"Ricken","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.jns.2023.120830_bb0360","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s00415-018-9153-8","article-title":"Patient characteristics and outcome associations in AMPA receptor encephalitis","volume":"266","author":"Laurido-Soto","year":"2019","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2023.120830_bb0365","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.jns.2023.120830_bb0370","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jamaneurol.2015.1715","article-title":"Clinical Spectrum of encephalitis associated with antibodies against the \u03b1-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic acid receptor: case series and review of the literature","volume":"72","author":"Joubert","year":"2015","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.jns.2023.120830_bb0375","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/NRL.0000000000000283","article-title":"GABA-B receptor encephalitis triggered by enterovirus encephalitis in a patient with small cell lung cancer: a case report","volume":"25","author":"Kim","year":"2020","journal-title":"Neurologist."},{"key":"10.1016\/j.jns.2023.120830_bb0380","doi-asserted-by":"crossref","first-page":"577705","DOI":"10.1016\/j.jneuroim.2021.577705","article-title":"Anti-GABAB receptor encephalitis associated with combined small cell lung carcinoma","volume":"360","author":"Chao","year":"2021","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.jns.2023.120830_bb0385","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.21037\/tcr-20-2769","article-title":"Anti-GABAB receptor antibodies with autoimmune encephalitis in clear cell renal cell carcinoma: a case report","volume":"10","author":"Wang","year":"2021","journal-title":"Transl. Cancer Res."},{"issue":"1","key":"10.1016\/j.jns.2023.120830_bb0390","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2023.120830_bb0395","doi-asserted-by":"crossref","first-page":"200","DOI":"10.5761\/atcs.cr.17-00135","article-title":"A case of paraneoplastic limbic encephalitis in a patient with invasive thymoma with anti-glutamate receptor antibody-positive cerebrospinal fluid: a case report","volume":"24","author":"Inoue","year":"2018","journal-title":"Ann. Thorac. Cardiovasc. Surg."},{"issue":"12","key":"10.1016\/j.jns.2023.120830_bb0400","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.jns.2023.120830_bb0405","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12883-019-1358-7","article-title":"Anti-\u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor GluR2 encephalitis in a myasthenia gravis patient with complete thymectomy: a case report","volume":"19","author":"Luo","year":"2019","journal-title":"BMC Neurol."},{"issue":"5","key":"10.1016\/j.jns.2023.120830_bb0410","doi-asserted-by":"crossref","first-page":"e1032","DOI":"10.1212\/NXI.0000000000001032","article-title":"Argonaute autoantibodies as biomarkers in autoimmune neurologic diseases","volume":"8","author":"Do","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.jns.2023.120830_bb0415","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","article-title":"Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen","volume":"9","author":"Lancaster","year":"2010","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.jns.2023.120830_bb0420","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00415-018-9132-0","article-title":"Isolated seizures are a common early feature of paraneoplastic anti-GABAB receptor encephalitis","volume":"266","author":"Maureille","year":"2019","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2023.120830_bb0425","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1001\/jamaneurol.2013.1955","article-title":"Patient with homer-3 antibodies and cerebellitis","volume":"70","author":"H\u00f6ftberger","year":"2013","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.jns.2023.120830_bb0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yebeh.2011.11.029","article-title":"Proposition: limbic encephalitis may represent limbic status epilepticus. A review of clinical and EEG characteristics","volume":"24","author":"Kaplan","year":"2012","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jns.2023.120830_bb0435","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.parkreldis.2017.08.017","article-title":"Paraneoplastic autoimmune movement disorders","volume":"44","author":"Lim","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2023.120830_bb0440","first-page":"024","article-title":"The management of LG1-associated encephalitis that presents with acute impaired consciousness","volume":"5","author":"\u00c7etin","year":"2022","journal-title":"Int J Neurodegener Dis."},{"issue":"4","key":"10.1016\/j.jns.2023.120830_bb0445","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/jnnp.68.4.479","article-title":"Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone","volume":"68","author":"Keime-Guibert","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"16","key":"10.1016\/j.jns.2023.120830_bb0450","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1111\/1759-7714.14070","article-title":"Clinical characteristics of paraneoplastic neurological syndrome related to different pathological lung cancers","volume":"12","author":"Ma","year":"2021","journal-title":"Thorac Cancer."},{"issue":"9","key":"10.1016\/j.jns.2023.120830_bb0455","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41571-019-0194-4","article-title":"Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors","volume":"16","author":"Graus","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.jns.2023.120830_bb0460","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1001\/jamaneurol.2015.0749","article-title":"Paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies","volume":"72","author":"Ari\u00f1o","year":"2015","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.jns.2023.120830_bb0465","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/jnnp.60.4.388","article-title":"Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies","volume":"60","author":"Uchuya","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"9","key":"10.1016\/j.jns.2023.120830_bb0470","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1007\/s10072-023-06769-x","article-title":"Patient characteristics and outcome in patients with anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) encephalitis","volume":"44","author":"Lin","year":"2023","journal-title":"Neurol. Sci."},{"issue":"12","key":"10.1016\/j.jns.2023.120830_bb0475","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1586\/14737175.2015.1115720","article-title":"Immune therapy in autoimmune encephalitis: a systematic review","volume":"15","author":"Nosadini","year":"2015","journal-title":"Expert. Rev. Neurother."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X23002915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X23002915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:03:03Z","timestamp":1758384183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X23002915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":95,"alternative-id":["S0022510X23002915"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2023.120830","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune and paraneoplastic neurological disorders: A review of relevant neuroimaging findings","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2023.120830","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120830"}}